Pyridoxine prevents dysfunction of endothelial cell nitric oxide production in response to low-density lipoprotein

Atherosclerosis

Volumn 188, Issue 1, 2006, Pages 84-94

  Ji, Yong ^a,b   Diao, Jianxin ^a   Han, Yi ^a   Huang, Yan ^a   Bai, Hui ^a   Chen, Qi ^a   Fan, Leming ^a   Ferro, Albert ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Endothelial cells; Low density lipoproteins; Nitric oxide; Nitric oxide synthases; Pyridoxine

Indexed keywords

AMINO ACID; CALCIUM ION; CYCLIC GMP; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PYRIDOXINE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DRUG POTENCY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; INCUBATION TIME; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CYCLIC GMP; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDATIVE STRESS; PYRIDOXINE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; UMBILICAL CORD; VITAMIN B COMPLEX;

EID: 33746698993     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2005.10.035     Document Type: Article

References (42)

1. Vita J.A., Treasure C.B., Nabel E.G., et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81 (1990) 491-497
2. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., and Deanfield J.E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 24 (1994) 1468-1474
3. Cai H., and Harrison D.G. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87 (2000) 840-844
4. Kinlay S., and Ganz P. Role of endothelial dysfunction in coronary artery disease and implications for therapy. Am J Cardiol 80 (1997) 11I-16I
5. Ross R. Atherosclerosis; an inflammatory disease. N Engl J Med 340 (1999) 115-126
6. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 315 (1986) 1046-1051
7. Chowienczyk P.J., Watts G.F., Cockcroft J.R., and Ritter J.M. Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemia. Lancet 340 (1992) 1430-1432
8. Casino P.R., Kilcoyne C.M., Cannon III R.O., Quyyumi A.A., and Panza J.A. Impaired endothelium-dependent vascular relaxation in patients with hypercholesterolemia extends beyond the muscarinic receptor. Am J Cardiol 75 (1995) 40-44
9. Galle J., Mülsch A., Büsse R., and Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of EDRF. Arterioscler Thromb 11 (1991) 198-203
10. Chin J.H., Azhar S., and Hoffman B.B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest 89 (1992) 10-18
11. Galle J., Schneider R., Winner B., et al. Glyc-oxidized LDL impair endothelial function more potently than oxidized LDL: role of enhanced oxidative stress. Atherosclerosis 138 (1998) 65-77
12. Kikuta K., Sawamura T., Miwa S., Hashimoto N., and Masaki T. High-affinity arginine transport of bovine aortic endothelial cells is impaired by lysophosphatidylcholine. Circ Res 83 (1998) 1088-1096
13. Ji Y., Han Y., Diao J., et al. Inhibition of endothelial nitric oxide generation by low-density lipoprotein is partially prevented by l-arginine and l-ascorbate. Atherosclerosis 176 (2004) 345-353
14. Ji Y., Han Y., Diao J., et al. Rabbit aortic endothelial dysfunction by low-density lipoprotein is attenuated by l-arginine, l-ascorbate and pyridoxine. Br J Pharmacol 140 (2003) 1272-1282
15. Kannan K., and Jain S.K. Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated U937 monocytes. Free Radic Biol Med 36 (2004) 423-428
16. Smith P.K., Krohn R.I., Hermanson G.T., et al. Measurement of protein using bicinchoninic acid. Anal Biochem 150 (1985) 76-85
17. Ferro A., Queen L.R., Priest R.M., et al. Activation of nitric oxide synthase by beta 2-adrenoceptors in human umbilical vein endothelium in vitro. Br J Pharmacol 126 (1999) 1872-1880
18. Hurairah H., and Ferro A. The role of the endothelium in the control of vascular function. Int J Clin Pract 58 (2004) 173-183
19. +) and nitric oxide synthesis in human fetal endothelial cells. J Physiol (Lond) 499 (1997) 135-140
20. + and nitric oxide synthase in human endothelial cells: association with membrane hyperpolarization. J Physiol (Lond) 489 (1995) 183-192
21. Guttormsen A.B., Solheim E., and Refsum H. Variation in plasma cystathionine and its relation to changes in plasma concentrations of homocysteine and methionine in healthy subjects during a 24-h observation period. Am J Clin Nutr 79 (2004) 76-79
22. Drexler H., Zeiher A.M., Meinzer K., and Just H. Correction of endothelial dysfunction in the coronary microcirculation of hypercholesterolaemic patients by l-arginine. Lancet 338 (1991) 1546-1550
23. Creager M.A., Gallagher S.J., Girerd X.J., et al. l-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest 90 (1992) 1248-1253
24. Clarkson P., Adams M.R., Powe A.J., et al. Oral l-arginine improves endothelium-dependent dilation in hypercholesterolaemic young adults. J Clin Invest 97 (1996) 1989-1994
25. Ting H.H., Timimi F.K., Haley E.A., et al. Vitamin C improves endothelium-dependent vasodilation in forearm resistance vessels of humans with hypercholesterolemia. Circulation 95 (1997) 2617-2622
26. Jeserich M., Schindler T., Olschewski M., et al. Vitamin C improves endothelial function of epicardial coronary arteries in patients with hypercholesterolaemia or essential hypertension-assessed by cold pressor testing. Eur Heart J 20 (1999) 1676-1680
27. Perticone F., Ceravolo R., Maio R., et al. Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients. Atherosclerosis 152 (2000) 511-518
28. Peterson T.E., Poppa V., Ueba H., et al. Opposing effects of reactive oxygen species and cholesterol on endothelial nitric oxide synthase and endothelial cell caveolae. Circ Res 85 (1999) 29-37
29. Moat S.J., Lang D., McDowell I.F., et al. Folate, homocysteine, endothelial function and cardiovascular disease. J Nutr Biochem 15 (2004) 64-79
30. Starkbaum G., and Harlan J.M. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine. J Clin Invest 77 (1986) 1370-1376
31. Wall R.T., Harlan J.M., Harker L.A., and Striker G.E. Homocysteine-induced endothelial cell injury in vitro: a model for the study of vascular injury. Thromb Res 18 (1980) 113-121
32. Lang D., Kredan M.B., Moat S.J., et al. Homocysteine-induced inhibition of endothelium-dependent relaxation in rabbit aorta: role for superoxide anions. Arterioscler Thromb Vasc Biol 20 (2000) 422-427
33. Topal G., Brunet A., Millanvoye E., et al. Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic Biol Med 36 (2004) 1532-1541
34. Pritchard Jr. K.A., Groszek L., Smalley D.M., et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res 77 (1995) 510-518
35. Stroes E., Kastelein J., Cosentino F., et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J Clin Invest 99 (1997) 41-46
36. Fukuda Y., Teragawa H., Matsuda K., et al. Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolaemia. Heart 87 (2002) 264-269
37. Martens F.W., and Hoskins D.W. Failure of parenterally administered pyridoxine to influence serum cholesterol levels and development of atherosclerosis in cholesterol-fed rabbits. Circ Res 6 (1958) 159-162
38. Khayyal M.T., Khayyal M.A., Sharaf H.M., et al. Effect of magnesium pyridoxal 5-phosphate glutamate on vascular reactivity in experimental hypercholesterolemia. Drugs Exp Clin Res 24 (1998) 29-40
39. Hofmann M.A., Lalla E., Lu Y., et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model. J Clin Invest 107 6 (2001) 675-683
40. Schnyder G., Roffi M., Pin R., et al. Decreased rate of coronary restenosis after lowering of plasma homocysteine levels. N Engl J Med 345 (2001) 1593-1600
41. Schnyder G., Roffi M., Flammer Y., Pin R., and Hess O.M. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 288 (2002) 973-979
42. Said H.M., Ortiz A., and Ma T.Y. A carrier-mediated mechanism for pyridoxine uptake by human intestinal epithelial Caco-2 cells: regulation by a PKA-mediated pathway. Am J Physiol Cell Physiol 285 (2003) C1219-C1225